Difference between revisions of "PaLM Conf Minutes 2017-Apr-12"
Jump to navigation
Jump to search
Line 96: | Line 96: | ||
</ul> | </ul> | ||
</ul> | </ul> | ||
+ | |||
+ | <ul> | ||
+ | <li><strong>2nd hour</strong> | ||
+ | <ul> | ||
+ | <li>SET profile updates (Alessandro)</li> | ||
+ | <ul> | ||
+ | <li>Shared last version of Vol 1 (includes biobank use case) just prior to Connetacthon</li> | ||
+ | <li>Please send updates and edits to Alessandro prior to F2F</li> | ||
+ | <li>Alessandro & Francesca will work on Volume 2 as preparation for F2F</li> | ||
+ | <ul> | ||
+ | <li>Start with Specimen Dam – it is being balloted right now</li> | ||
+ | <li>Define the meta data and which elements will be mandatory vs preferred / conditional / optional</li> | ||
+ | <li>Including trigger events, value sets to describe the actions performed on the specimen</li> | ||
+ | <li>Specimen CMET is in current ballot – Lorraine shared with Francois</li> | ||
+ | </ul> | ||
+ | </ul> | ||
+ | <li>LSH updates (John) – not on</li> | ||
+ | <li>Other topics?</li> | ||
+ | </ul> | ||
+ | </li> | ||
+ | </ul> | ||
+ | <ul> | ||
+ | <ul> | ||
+ | |||
+ | </ul> | ||
+ | </ul> | ||
+ | <ul> | ||
+ | <ul> | ||
+ | <ul> | ||
+ | <li>Connectathon update in Venice</li> | ||
+ | <ul> | ||
+ | <li>Tested more for lab profiles – about 40 tests were performed J</li> | ||
+ | <li>LAW and LTW and XD-Lab (most popular) these are all part of regulatory European eHealth interoperability framework</li> | ||
+ | <li>Will have complete update at F2F</li> | ||
+ | </ul> | ||
+ | <li>Transfusion medicine</li> | ||
+ | <ul> | ||
+ | <li>How to report reaction to blood transfusion – per standard it is in the product level in the BXA? segment</li> | ||
+ | <li>In patient care in practice this is not associated to single unit, it is documented at the encounter level NLY – considering HL7 CR for discussion</li> | ||
+ | <li>Need to document a specific event – do we need new full message, or a segment that can be added to existing messages after related segments</li> | ||
+ | <li>Look at what patient care has</li> | ||
+ | <li>Or use REL to link to product</li> | ||
+ | <li>This still needs more research</li> | ||
+ | <li>Can we use ORU message – it is an observation on the patient?</li> | ||
+ | <li>Possible – but what is the workflow associated with this?</li> | ||
+ | <li>Do not want to confuse this with other observations / results</li> | ||
+ | <li>Other example is blood type – ore closer related to patient and less changeable</li> | ||
+ | <li>Product level documentation probably came from blood suppliers</li> | ||
+ | </ul> | ||
+ | </ul> | ||
+ | </ul> | ||
+ | </ul> | ||
+ | <b>Next Meeting: 17 May 2017 at 8:00am (central) |
Latest revision as of 09:46, 13 April 2017
Back to IHE Pathology and Laboratory Medicine (PaLM) Domain
Back to IHE Pathology and Laboratory Medicine (PaLM)Technical Committee Page
Recording
The recording for this meeting can be downloaded [ HERE]
Attendees
Francois Macary, Co-Chair | Phast |
Riki Merrick, Co-Chair | APHL |
Carolyn Knapik | CAP, secretariat |
Alessandro Sulis | CRS4 |
Dan Rutz | Epic |
Ed Heierman | Abbott |
Filip Migom | MIPS |
Francesca Frexia | CRS4 |
Gunter Haroske | IHE Germany |
James Wulkan | Beckman/Coulter |
JD Nolen | Cerner |
Jessica Poisson | Duke |
Jurgen De Decker | MIPS |
Minutes
- 1st hour
- Agenda review
- May F2F agenda (Francois, Riki)- Current F2F agenda items:
- Held at JAHIS – address and hotels have been shared
- SET (Alessandro will be remote, move to afternoons)
- LCC (Riki in person, move to early in the day) – goal to get to ready for publishing for Public Comment
- LSH (John)
- APSR 2.0 (Gunter will be remote, so move to afternoons)
- White paper (Raj in person)
- New release of TF based on CPs (just a few) – to be published in June 2017 (Francois in person) – just 3 CPs, mostly from LAW update – (Ed not in person, so adjust time, if not covered by Francois), want to ballot before the meeting – start ballot 4/25 – Ed to prepare by then
- Digital Pathology workflow – Raj will reach out to at least get a status update (Raj in person, move to early in the day)
- Around the world updates (in PM)
- Improve worldwide marketing – learn from Japan’s efforts
- Transfusion medicine workflow (Dan / Jessica will be remote (9 AM is good slot for him), Filip )
- Remote participation will be provided by JAHIS using CAP GTM, with voice on IP
- Current F2F agenda can be viewed here: http://wiki.ihe.net/index.php/PaLM_F2F_Agenda_2017-May
- Next month’s call was scheduled during HL7 WGM – move to 5/17/2017
- SNOMED CT free subsets for IHE (Francois)
- Drafted starter set has been complemented since last month – please review and add on https://docs.google.com/spreadsheets/d/1rONueGvi6pxO6CKHpad90n7zEBya0Gxz2FSTQt5ILhY/edit#gid=0
- Use APSR 2.0 value sets to add additional concept candidates -> Gunter
- Is now on the agenda for the DCC – will be discussed again with the intent that every domain submits its own candidate content into this common spreadsheet
- If you want to contribute to the spreadsheet, send email to Francois so he can invite you
- 2nd hour
- SET profile updates (Alessandro)
- Shared last version of Vol 1 (includes biobank use case) just prior to Connetacthon
- Please send updates and edits to Alessandro prior to F2F
- Alessandro & Francesca will work on Volume 2 as preparation for F2F
- Start with Specimen Dam – it is being balloted right now
- Define the meta data and which elements will be mandatory vs preferred / conditional / optional
- Including trigger events, value sets to describe the actions performed on the specimen
- Specimen CMET is in current ballot – Lorraine shared with Francois
- LSH updates (John) – not on
- Other topics?
- Connectathon update in Venice
- Tested more for lab profiles – about 40 tests were performed J
- LAW and LTW and XD-Lab (most popular) these are all part of regulatory European eHealth interoperability framework
- Will have complete update at F2F
- Transfusion medicine
- How to report reaction to blood transfusion – per standard it is in the product level in the BXA? segment
- In patient care in practice this is not associated to single unit, it is documented at the encounter level NLY – considering HL7 CR for discussion
- Need to document a specific event – do we need new full message, or a segment that can be added to existing messages after related segments
- Look at what patient care has
- Or use REL to link to product
- This still needs more research
- Can we use ORU message – it is an observation on the patient?
- Possible – but what is the workflow associated with this?
- Do not want to confuse this with other observations / results
- Other example is blood type – ore closer related to patient and less changeable
- Product level documentation probably came from blood suppliers
Next Meeting: 17 May 2017 at 8:00am (central)